These platforms are highly engineered medical devices studied under controlled conditions, often in early-stage clinical trials
In the Phase 2 trial published in the New England Journal of Medicine, participants receiving the highest dose of retatrutide (12mg weekly) achieved a mean body weight reduction of 24.2% over 48 weeks
The most frequently reported adverse effects of GLP-1 receptor agonists are gastrointestinal in nature, including nausea, vomiting, diarrhea, constipation, and abdominal discomfort
Zepbound Add-ons: In-network wellness components, such as nutrition, therapy, and risk management via Wellness Plus Bottom Line Mochi Health offers a well-rounded GLP-1 program with insurance integration, making it a solid pick if your plan covers brand-name meds